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Introduction
Broad consensus exists that advocacy and policy engagement form 
a crucial part of a comprehensive public health strategy and are cen-
tral to recent achievements in tobacco control.1 Scholars and advo-
cates argue that tobacco control alliances have been instrumental in 
challenging the tobacco industry’s previous political dominance2–4 
(Weishaar H., Amos A., and Collin J., unpublished data, June 2013) 
and attaining tobacco control policy successes.5–9 In contrast to the 
largely conceptual and anecdotal literature on advocacy coalitions, 
there is a dearth of studies which draw on empirical data to systemati-
cally investigate coalition-building and identify factors which enhance 
advocacy coalitions’ impact on policy. Drawing on the development 
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Abstract
Introduction: Coalitions of supporters of comprehensive tobacco control policy have been crucial 
in achieving policy success nationally and internationally, but the dynamics of such alliances are 
not well understood.
Methods: Qualitative semi-structured, narrative interviews with 35 stakeholders involved in devel-
oping the European Council Recommendation on smoke-free environments. These were the-
matically analyzed to examine the dynamics of coalition-building, collaboration and leadership 
in the alliance of organizations which successfully called for the development of comprehensive 
European Union (EU) smoke-free policy.
Results: An alliance of tobacco control and public health advocacy organizations, scientific institu-
tions, professional bodies, pharmaceutical companies, and other actors shared the goal of fighting 
the harms caused by second-hand smoke. Alliance members jointly called for comprehensive EU 
smoke-free policy and the protection of the political debates from tobacco industry interference. 
The alliance’s success was enabled by a core group of national and European actors with long-
standing experience in tobacco control, who facilitated consensus-building, mobilized allies and 
synchronized the actions of policy supporters. Representatives of Brussels-based organizations 
emerged as crucial strategic leaders.
Conclusions: The insights gained and identification of key enablers of successful tobacco control 
advocacy highlight the strategic importance of investing into tobacco control at European level. 
Those interested in effective health policy can apply lessons learned from EU smoke-free policy to 
build effective alliances in tobacco control and other areas of public health.
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of comprehensive European Union (EU) smoke-free policy as a recent 
example of successful EU tobacco control policy, this article is the first 
to empirically analyze a tobacco control alliance in EU policymaking.
The acknowledgement of the critical role of advocacy and coali-
tion-building in achieving effective tobacco control policies is in line 
with concepts which have been developed to increase understanding 
of advocacy coalitions, notably Sabatier and Jenkins-Smith’s advo-
cacy coalition framework and Keck and Sikkink’s transnational 
advocacy network. Sabatier and Jenkins-Smith define advocacy 
coalitions as groups of political actors who engage in policymak-
ing, share similar values, beliefs and positions and interact regu-
larly in order to influence policy within a given area.10,11 Keck and 
Sikkink’s work focuses on political actors’ efforts to tackle domestic 
and international policy issues simultaneously by building transna-
tional coalitions.12 Political analysts agree that the joint presenta-
tion of political interests is useful for demonstrating solidarity 
and broad support, and attracting decision makers’ attention,13–16 
thus placing those who build coalitions at a significant advantage 
when trying to shape policymaking.12 The literature, however, is 
less clear about which characteristics of coalitions and mechanisms 
of partnership-working enhance advocacy success. Issue, network, 
and context characteristics have been discussed as contributing fac-
tors. Mahoney, for example, argues that a strong urge to combine 
forces amid a common or immediate threat means that issues of 
high salience and controversy are particularly likely to generate 
coalition-building,16 while Keck and Sikkink emphasize advocates’ 
characteristics and relationships as determining the performance 
and success of coalitions.12
This study focuses on the European Council Recommendation 
on smoke-free environments, a nonbinding document recommend-
ing that member states adopt and implement policies to effectively 
protect their citizens from exposure to second-hand smoke (SHS).17 
This policy was adopted in November 2009 by the Council of the 
European Union after almost 3  years of negotiations centered on 
possible exemptions to the policy and the type of policy for which 
consensus was achievable. By calling for comprehensive national 
smoke-free policies, the adopted policy document largely reflects 
the position of advocates who jointly supported comprehensive EU 
smoke-free policy (subsequently referred to as the “smoke-free alli-
ance”). By analyzing the composition of the smoke-free alliance, the 
dynamics of coalition-building, collaboration and leadership, alli-
ance members’ priorities and strategic decisions to pursue unity, and 
their assessment of the alliance’s success, this paper aims to provide 
insights into successful public health advocacy and offer lessons for 
other areas of EU public health policy.
Methods
A review of policy documents related to the development of the 
European Council Recommendation on smoke-free environments 
identified 175 individuals involved in the policy process, their organ-
izational affiliations and policy stance. Stakeholders were assigned 
to three groups: (a) key actors crucial to the process (e.g., repre-
sentatives of EU institutions and member states strongly involved in 
the policy’s development, n = 49), (b) stakeholders with considerable 
interest in the process (e.g., other actors involved in the development 
of the policy, n = 59), and (c) individuals who had shown an inter-
est but had not directly engaged in the process (n = 67). Drawing 
primarily from the first category, interviewees were selected using 
purposive sampling, aimed at recruiting representatives that varied 
by type of organization, policy position, geographical remit, national 
affiliation, and involvement at different stages of the policy process.
Forty-eight individuals were contacted for interview of which 
six declined and five did not respond. After being contacted via tel-
ephone or e-mail and informed about the study’s design, content 
and purpose, all interviewees provided written informed consent. 
Thirty-five stakeholders were interviewed across 29 one-to-one 
and three paired interviews. Interviews were conducted with 18 
representatives of health-related organizations (encompassing 
civil society organizations focusing on tobacco control or public 
health, scientific institutions centered on tobacco-related research 
and organizations representing health professionals), five policy-
makers (politicians and civil servants) and representatives of the 
tobacco industry (four), social partner organizations (four), the 
ventilation industry (one) and other commercial sectors (three) 
(Table 1). Twenty-seven interviews were conducted in person and 
five via telephone. Interviews included a narrative section on inter-
viewees’ experiences of the policy process, and a semi-structured 
section exploring their policy positions, collaboration with other 
actors, coalition leadership and assessment of partnership-working. 
Interviews were conducted March to July 2011, lasted, on average, 
60 min and were fully transcribed. A hermeneutic analytical proce-
dure was developed, based upon that described by Bauer,18 involv-
ing an iterative process of identifying recurring themes, comparison 
across sub-samples and systematically applying a coding frame-
work to the data set. Interviews were read several times to identify 
thematic clusters and themes.19 Transcripts were then systematically 
coded according to these themes using QSR NVivo Version 7.20 
Ethical approval was obtained from the Research Ethics Committee 
at the School of Health in Social Science of the University of 
Edinburgh. For a detailed account of the study’s methodology, see 
Weishaar et al.21 Quotes used in the results section indicate the type 
of organization to which the participant belonged.
Results
Members of the smoke-free alliance jointly promoted the follow-
ing three key messages in the policy debates: (a) population health 
should be improved by protecting EU citizens from the harms 
caused by SHS; (b) comprehensive smoke-free policies without 
exemptions are the only way to achieve effective protection from 
SHS; and (c) given that tobacco companies are the main vector of 
the tobacco epidemic, tobacco industry representatives should have 
no opportunity to influence the process of developing smoke-free 
policies. Table 2 provides selected examples both of how the key 
messages were communicated and of developments in the policy 
process which indicate that the messages met with some success. 
Individual members of the alliance, including representatives of the 
pharmaceutical sector, health professional bodies and organiza-
tions focused on specific diseases, also put considerable efforts into 
emphasizing smoking cessation as a flanking measure to smoke-
free policies. While largely demonstrating agreement on the above 
three key messages, alliance members were almost evenly divided 
on preferred type of policy. Half advocated for binding legislation, 
whereas the other half argued for a nonbinding recommendation 
(based on the assumption that this policy type would be more likely 
to receive political support).
The data clearly indicate that members of the smoke-free alli-
ance recognized a need to demonstrate unity on the issue of EU 
smoke-free policy and were committed to collaboration to enhance 
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Table 1. List of Interviewees
Decision makers
 Anna Jassem-Staniecka, Policy Officer, European Commission Directorate General for Health and Consumers, Unit 4, Belgium
 Alick-James Morris, Policy Officer, European Commission Directorate General for Employment, Social Affairs and Inclusion in the  
Unit responsible for health, safety and hygiene at work, Luxembourg
 Terje Peetso, Policy Officer, European Commission Directorate General for Health and Consumers, Unit 4, Belgium
 A representative of the European Economic and Social Committee, Belgium
 A representative of an EU institution, Belgium
Representatives of the public health sector
 Florence Berteletti-Kemp, Director of the Smokefree Partnership, Belgium
 Gregor Breucker, Member of the European Network for Workplace Health Promotion, Germany
 Antonella Cardone, Director of the Global Smokefree Partnership, Italy
 Magdalena Cedzyńska, Member of International Network of Women Against Tobacco Europe Executive Board, Poland
 Norma Cronin, Health Promotion Manager Tobacco Control at the Irish Cancer Society and Member of International Network of Women Against 
Tobacco Europe Executive Board, Ireland
 Sheila Duffy, Chief Executive Action on Smoking and Health Scotland, United Kingdom
 Fiona Godfrey, previous Advocacy Director at the European Respiratory Society and European Regional Advisor for Tobacco Control at the 
International Union against Tuberculosis and Lung Cancer, Belgium
 Margaretha Haglund, Tobacco Control Policy Expert at Swedish tobacco control think tank Tobaksfakta and Member of International Network of 
Women Against Tobacco Europe Executive Board; previously civil servant at the Swedish National Institute for Public Health (Head of National 
Tobacco Control Programme and Tobacco Control Expert), Sweden
 Luk Joossens, Advocacy Officer of the Association of European Cancer Leagues, Belgium
 Jean King, Director of Tobacco Control, Cancer Research UK, United Kingdom
 Mervi Hara, Director at Finland’s Action on Smoking and Health and Member of International Network of Women Against Tobacco Europe 
Executive Board, Finland
 Martina Pötschke-Langer, Director of the unit for cancer prevention at the German Cancer Research Centre and the WHO Collaborating Centre 
for Tobacco Control and Member of International Network of Women Against Tobacco Europe Executive Board, Germany
 Trudy Prins, Member of International Network of Women Against Tobacco Europe Executive Board; previous Director of the Dutch Expert Centre 
on Tobacco Control and President of the European Network for Smoking and Tobacco Prevention, Netherlands
 Uwe Prümel-Philippsen, Director of the German Federal Association for Prevention and Health Promotion, Germany
 Ailsa Rutter, Director of Fresh—Smoke Free North East, UK
 Nick Schneider, Science Manager at the unit for cancer prevention at the German Cancer Research Centre and the WHO Collaborating Centre for 
Tobacco Control, Germany
 Gerhard Siemon, Member of the Board of Trustees of the German Lung Foundation, Germany
 Friedrich Wiebel, President of the German Medical Action Group Smoking and Health, Germany
Representatives of the tobacco sector
 Cynthia Fürste, Corporate Affairs Manager Western Europe British American Tobacco Representation Brussels, Belgium
 Bas Tonnaer, Head of Corporate and Regulatory Affairs at British American Tobacco Switzerland SA, Switzerland
 Peter van der Mark, General Secretary of the European Smoking Tobacco Association, Belgium
 Representative of European Tobacco Wholesalers
Representatives of social partner organizations
 Antje Gerstein, Director of the Brussels Representation of the German Employers’ Confederation, Belgium
 Helen Hoffmann, Advisor for Social Affairs, European Association of Crafts, Small and Medium-Sized Enterprises, Belgium
 Rebekah Smith, Senior Adviser for Social Affairs at BusinessEurope, Belgium
 Harald Wiedenhofer, General Secretary of the European Federation of Food, Agriculture and Tourism Trade Unions, Belgium
Representatives of the ventilation sector
 Hubert Koch, Director of Dr. Koch Consulting E.K., consultant of the European Alliance For Technical Non-smoker Protection, Germany
Representatives of other commercial sectors
 Brussels-based European public affairs expert
 Lobbyist
 Analyst
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advocacy success. Interviewees perceived coalition-building to be 
crucial for achieving policy success and highlighted the value of col-
laboration in influencing policymakers. This was described by one 
interviewee as reducing “complexity,” enhancing “power of persua-
sion” and demonstrating the presence of “strong interests”:
Politicians always like these kinds of alliances because they say: 
‘Preliminary debates have been held. Positions have been clarified. 
And…they have relieved us of some of the work.’ Because politi-
cians always have to balance the various stakeholders’ interests. 
And the better they have aligned their interests, the easier it is. 
(representative of the ventilation sector)
Table  3 outlines the four key factors identified as contributing to 
the alliance’s positive impact on policy: (a) composition, (b) priori-
ties and pursuit of unity, (c) collaboration, and (d) leadership and 
coordination.
Composition of the Alliance
The smoke-free alliance was comprised of advocacy organizations 
with an interest in public health, scientific institutions, professional 
organizations and pharmaceutical sector organizations. It included 
organizations centered on national, European and global tobacco 
control (e.g., national nonsmokers’ initiatives, the Framework 
Convention Alliance, the International Network of Women Against 
Tobacco) and broader health-related issues (e.g., the European 
Public Health Alliance, the British Medical Association, pharma-
ceutical companies). Tobacco control advocates indicated that they 
prioritized recruiting diverse allies to convey broad public support 
for comprehensive EU smoke-free policy; the alliance’s heterogene-
ity reflected a strategic effort to “develop a coalition which was not 
only tobacco control” (tobacco control advocate) and to present a 
“united front” across public health (public health advocate). Such 
Table 2. Key Messages, Examples of their Communication and Policy Developments Indicating Success of Such Messages
Key messages Examples of message communication Policy developments
Population health 
should be improved 
by protecting 
European Union 
(EU) citizens from 
the harms caused 
by second-hand 
smoke (SHS).
Submission by the European Network for Smoking Prevention: 
“The dangerous health effects of secondhand smoke have been 
documented in over 20 reports…A cautious estimate is that 
exposure to secondhand smoke kills at least 79 000 people in the 
EU each year…In addition, secondhand smoke causes a great deal 
of respiratory diseases and is a major risk factor that exacerbates 
attacks for people with asthma, allergic illnesses, chronic obstructive 
pulmonary disease (COPD) and other chronic diseases leading to 
social and work exclusion and unnecessary illness.”32
The rationale underlying the Council 
Recommendation on smoke-free 
environments highlights that SHS is “is a 
wide spread source of mortality, morbidity 
and disability in the European Union” and 
that “people have the right to a high level of 
health protection and should be protected 
from exposure to tobacco smoke”.17
Interview with public health advocate: “We really want to promote 
health, and health issues.”
Interview with tobacco control advocate: “The common interests of 
saving citizens lives (unites organisations working on tobacco control 
in Europe). So they are committed to this, and this is what all of 
them have in common.”
Comprehensive 
smoke-free policies 
without exemptions 
are the only way 
to achieve effective 
protection from 
SHS.
Submission by ASH England: “Experience from the UK shows that 
anything less than a comprehensive approach would substantially 
weaken the smoke-free measure, thus offering less than optimal 
health protection.”33
The final policy document recommends member 
states to “provide effective protection 
from exposure to tobacco smoke in indoor 
workplaces, indoor public places, public 
transport and, as appropriate, other public 
places”17 in line with Framework Convention 
on Tobacco Control (FCTC) article 
8. The guidelines to FCTC article 8 state 
that effective measures “require the total 
elimination of smoking and tobacco smoke 
in a particular space or environment in order 
to create a 100% smoke-free environment.”35
Submission by the German Cancer Research Centre: “Article 8 of the 
WHO Framework Convention (protection from exposure to tobacco 
smoke) obligates Parties to take effective steps to provide protection 
from exposure to tobacco smoke. Effective measures require the total 
elimination of smoking and tobacco smoke in a particular space or 
environment in order to create a 100% smoke-free environment. 
There is no safe level of exposure to tobacco smoke…Approaches 
other than 100% smoke-free environments, including ventilation, air 
filtration and the use of designated smoking areas…have repeatedly 
been shown to be ineffective.”34
Interview with tobacco control advocate: “So the framing of the 
problem, we were all in agreement about…We wanted 100% smoke-
free with no exemptions. And we were…very, very clear on that.”
Given that tobacco 
companies are the 
main vector of the 
tobacco epidemic, 
tobacco industry 
representatives 
should have 
no opportunity 
to influence 
the process of 
developing smoke- 
free policies.
Submission by the European Public Health Alliance: “We would like to 
reiterate that the tobacco industry must be excluded from smoke free 
policy debates because of the unique role of its products in causing 
harm and because of its track record of deceptive behaviour.”36
In the consultation meeting with stakeholders 
initiated by the European Commission, public 
health and civil society representatives objected 
to being consulted in a joint meeting with 
tobacco industry representatives, arguing that 
tobacco manufacturers and their allies should 
not be treated as legitimate stakeholders. 
Accordingly, the meeting minutes indicate 
that two separate meetings took place, 
one with tobacco and ventilation industry 
representatives, and the other with health 
experts, civil society and social partners.
Interview with tobacco control advocate: “Tobacco companies can put 
in their views in a paper exercise but that’s as far as it should go. 
They should not be treated like normal stakeholders and that’s made 
very clear in the FCTC article 5.3.”
Interview with analyst: “The argumentation from the NGOs and 
researchers was that the tobacco industry in earlier discussions had, 
in their opinion, ruined the complete discussion by coming up with 
all sorts of nonsensical arguments.”
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efforts seemingly met with success, illustrated by tobacco industry 
representatives and politicians referring to the supporters of compre-
hensive EU smoke-free policy as “a one-issue movement” represent-
ing “the voice of the health sector.”
Key strategic decisions included coalition-building with the 
pharmaceutical sector. While civil society organizations’ messages 
emphasized the need to adopt smoke-free policies, pharmaceutical 
industry messages focused on smoking cessation as a flanking meas-
ure to such policies. However, the pharmaceutical sector’s input was 
valued as increasing the alliance’s financial resources, opening up 
additional opportunities for communication with decision makers 
and enhancing the alliance’s visibility. For example, dinner debates 
were held in the European Parliament, funded by the pharmaceuti-
cal sector and co-organized with European health organizations and 
professional bodies.22,23 Interviewees viewed such events as helpful in 
raising awareness, facilitating debates about comprehensive smoke-
free policy, and increasing the prominence of the smoke-free alliance.
Organizations representing researchers, academics and pro-
fessionals also showed considerable engagement and close col-
laboration with advocacy organizations. These actors were seen as 
enhancing the credibility of the smoke-free alliance, being perceived 
within the coalition as conveying “authority” and being “taken…
more seriously than an advocacy group.” A representative of a sci-
entific institution stressed that decision makers particularly valued 
the input and expertise provided by academics and professionals, 
assigning more weight to their positions and statements.
Priorities and Pursuit of Unity
Alliance members shared a common motivation to fight the harms 
caused by SHS, with members describing unity based on a “shared 
vision” to “save citizens’ lives” (public health advocates) and “change 
society for the better” (European public affairs expert). This “common 
interest” (tobacco control advocate) resulted in two lobbying mes-
sages being consistently advanced by alliance members: the need for 
comprehensive smoke-free policy without exemptions and protection 
of the policy process from tobacco industry interference. Interviewees 
described earlier international negotiations for the World Health 
Organization Framework Convention on Tobacco Control (FCTC) 
as easing development of a clear set of agreed measures:
[Reaching agreement] is not usually difficult. Especially now with 
the FCTC, because that is a very strong framework for us…The 
FCTC is a good blueprint. (public health advocate)
International consensus about effective tobacco control strategies 
helped advocates to publicly advance “a unified position on SHS” 
(tobacco control advocate) in the EU context.
Alliance members were also united in their identification of the 
tobacco industry as an opponent and the view that the industry’s 
engagement in the debates would threaten the adoption of effec-
tive policy. Tobacco control advocates, in particular, perceived the 
tobacco industry and its representatives as “a clear and tangible 
enemy”, requiring a strong united front and response. Referring to 
the long history of tobacco industry efforts to undermine tobacco 
control policies, one advocate reflected that “maybe the fact that 
the tobacco companies (had previously) behaved so outrageously 
helped to unite us.” Advocates also identified an imbalance of 
resources between “the brilliantly positioned tobacco indus-
try” and those working in tobacco control; the risk that tobacco 
companies would exploit any dissent created an imperative to 
collaborate:
We need to be united in what we are prioritising at any one time 
because we have very limited resources. Also, if there are different 
voices or different policies being promoted, the opposition will 
do all they can to exploit that. So it’s very important that we can 
reach an agreed position and agreed policies. (tobacco control 
advocate)
Collaboration
Trust emerged as a crucial element of collaboration among mem-
bers of the smoke-free alliance. Advocates reported building on their 
long-standing experience of jointly lobbying for national, European 
and international public health policies, which had promoted con-
sensus and trust, refined advocacy strategies and created strong per-
sonal and professional relationships:
We were a group of people who, by that point, had been work-
ing together for a long time on tobacco control and other health 
issues sometimes. We knew each other, we trusted each other, we 
respected each other’s judgment. (public health advocate)
Table 3. Factors Identified as Contributing to the Alliance’s Impact on Policy
Factors identified as contributing to  
the alliance’s impact on policy Specification
1. Composition of the alliance Different types of organization
Issue-specific organizations and organizations with a broader remit
Actors with resources to financially support the campaign
Input from researchers and health professionals
2. Priorities and pursuit of unity Shared vision about reducing harms from tobacco and second-hand smoke
Consensus on favored policy measures
Agreement on key lobbying messages
Shared identification of, and resistance to, opposition
3. Collaboration Personal interaction, long-term collaboration and trust
Information exchange
Pooling of resources
4. Leadership and coordination Lead actor(s) with understanding of the policy issue and policy process and ability to provide  
strategic direction
Core group of actors committed to the issue and able to engage in advocacy and levy resources
Ability to mobilize support
Good working relationships between organizations supporting the issue across different levels of 
governance (local, national, European Union EU, global)
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Formal organizational networks, online communities, and interna-
tional conferences were seen as crucial opportunities to reinforce 
existing contacts and as important venues for information exchange 
and policy discussion. Alliance members described using their net-
works to gather opinions about how to react to the policy proposal, 
obtain feedback and advice, mobilize allies to submit responses and 
exchange draft texts. Health advocates agreed that “sharing messages, 
information and intelligence” had been “vital” in achieving success 
and mentioned several practical benefits of coalition-building, includ-
ing knowledge transfer, reduced workload and increased efficiency:
The biggest advantage was the fact that we had access to each 
other. So we could tap into each other’s resources and each other’s 
knowledge…If you put all the intelligence of the people together 
it’s more than just the sum of all the people who are there. It adds 
something. (public health advocate)
Leadership and Coordination
A clear sign of key advocates’ recognition of the strategic value of 
pooling resources was the establishment of the European Smokefree 
Partnership (SFP). Created in 2005 by European and national 
tobacco control organizations in response to emerging discussions on 
EU smoke-free policy, this Brussels-based organization, aimed at pro-
moting tobacco control advocacy at the EU level, emerged as a key 
player in the debates. The SFP was highlighted by several interviewees 
as important in disseminating information, driving the agenda, mobi-
lizing actors, building partnerships and providing strategic direction. 
Viewed as the focal point of the alliance, the SFP was part of a group 
of representatives of European and national organizations who held 
key roles at national or European levels and were experienced in 
working together in EU lobbying. These individuals were described 
by several public health advocates as forming an informal European 
“strategy group”, which had held regular teleconference discussions 
of EU policy developments and strategies since the 1990s. The strat-
egy group members’ knowledge of and commitment to tobacco con-
trol and their relationships with each other were regarded as crucial 
assets. They subsequently led the lobbying campaign at national and 
European levels, mobilizing other organizations, facilitating collabo-
ration between supporters and coordinating action, thus allowing the 
sharing of resources and increasing efficiency.
Interviewees highlighted the importance of tobacco control advo-
cacy being led by Brussels-based organizations, whose proximity 
allowed them to keep “their finger on the pulse” (public health advo-
cate) and “be part of the day-to-day business with regard to information 
and the monitoring process” (tobacco industry representative). Also 
perceived as important were the lead organizations’ and particularly 
the SFP’s thorough understanding of the EU policy process, ability to 
assess likely support and opposition, and tactical approach to advocacy. 
Leadership and guidance from Brussels-based organizations was seen 
as crucial in helping member state advocates tailor messages to national 
decision makers and lobby for comprehensive EU smoke-free policy:
Someone has to be up there doing the guidance…to the countries: 
‘Now it’s the right time to do this, to write to your ministry. Now 
it’s the right time to talk to your MEPs in Brussels.’ Someone up 
there on the Brussels level has to give these instructions to the 
countries. (national tobacco control advocate)
Discussion
This article analyzes coalition-building and collaboration among 
supporters of effective EU tobacco control policy in the run-up to 
the Council Recommendation on smoke-free environments. It com-
plements previous work on advocacy coalitions which highlights the 
advantages of coalitions in terms of accessing, sharing and dissemi-
nating information, pooling resources, enhancing advocates’ abil-
ity to demonstrate solidarity, agreement and support for a policy 
position, garnering decision makers’ support and influencing policy 
processes.12,16 Our analysis provides evidence of the dynamics of the 
diverse alliance which supported comprehensive EU smoke-free pol-
icy and included advocacy organizations, scientific institutions, pro-
fessional organizations, and pharmaceutical sector organizations. 
At the core of the alliance, leading tobacco control advocates drove 
strategic decisions regarding coalition-building and the mobilization 
of actors with a broader remit. This resulted in the alliance being 
perceived as broadly representing the health sector, rather than a 
narrow tobacco control interest.
While heterogeneous, the alliance shared the common goal of 
fighting harms caused by SHS and agreed on and jointly advanced 
a small number of clear key messages: the need to protect EU citi-
zens from SHS by implementing comprehensive EU smoke-free 
policy without exemptions and to safeguard the policy process from 
tobacco industry interference. While, in line with the advocacy coali-
tion framework,10 normative beliefs about the primacy of health can 
be seen as the “glue” that held alliance members together, strategic 
agreement on key messages and actions and demonstrating unity 
seemed to be similarly important. Policy debates were thus focused 
on key broad messages, with disagreement on more specific issues 
(e.g., on stakeholders’ favored policy type or on flanking measures) 
subordinated given the priority afforded to demonstrating unanim-
ity. The analysis highlights that previous collaboration on tobacco 
control initiatives helped coalition members to agree on lobbying 
messages and contributed to successful coalition-building and col-
laboration on EU smoke-free policy. That advocates knew and relied 
on each other and had experience of working together was seen as 
facilitating alliance formation and cooperation, mirroring research 
by Klijn and colleagues about the importance of trust in governance 
networks.24 Awareness of limited resources, previous experience of 
tobacco industry successes in preventing effective public health policy 
and the common perception of the tobacco industry as a powerful 
enemy, served to unify and enhance cohesion among health advocates.
The analysis highlights the role of national and European lead 
organizations in facilitating effective advocacy and coalition-build-
ing for public health. While organizations such as the Bureau for 
Action on Smoking Prevention and the European Network for 
Smoking Prevention have been recognized as leaders of advocacy 
campaigns to advance previous EU tobacco control legislation,25 
our study shows that in this recent case, SFP was crucial in coordi-
nating the actions of organizations dispersed across member states 
from its base in Brussels. National lead organizations, on the other 
hand, focused on mobilizing allies in their respective member states. 
Such findings not only echo accounts of the importance of lead 
organizations within successful tobacco control alliances at national 
level,6,26,27 but highlight the importance of European advocacy lead-
ership. The analysis also shows that in addition to relying on SFP’s 
synchronization, alliance leadership was shared among a small 
number of organizations that devoted a considerable proportion of 
their resources to advancing a tobacco control agenda and coordi-
nating other actors. The close interaction, consensus-building and 
collaboration among this core group of national and Brussels-based 
advocates appeared as a key strength of the alliance, contributing to 
its ability to disseminate information and enlist allies, increasing its 
reach across national and European levels.
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This study identifies common values, unity among advocates and 
agreement on strategies as crucial factors for successful coalition-
building and public health advocacy. The specific features and chal-
lenges of advocacy alliances identified in this study also highlight the 
transnational dimension of alliances that operate in the EU context. 
This suggests that concepts like Keck and Sikkink’s transnational 
advocacy network12 might prove valuable when analyzing public 
health governance, transnational alliances, and the interactions that 
are characteristic of the EU policy process. Our analysis further high-
lights that organizations experienced in advocating and negotiating 
EU policymaking are particularly important to public health alliances 
operating at EU level. In line with the image of Brussels as an “insid-
er’s town”28 or a “bubble,”29 the findings indicate that the complexity 
and intricacies of the EU policy process increase the significance of 
Brussels-based actors who can “translate”, mediate and provide stra-
tegic guidance on “Brussels politics”. By identifying the considerable 
demands which such organizations are confronted with, including the 
need to keep a multitude of organizations informed and coordinate 
differing interests, the analysis suggests that leaders of European alli-
ances face particular challenges. Concepts of political entrepreneur-
ship, which focus on the key characteristics of actors with an ability to 
direct political processes,30,31 might usefully inform further analyses of 
the role of lead organizations in EU public health alliances.
This study identifies a number of features which appear to 
advance successful public health advocacy: mobilizing diverse actors 
beyond those with a circumscribed interest in a specific policy; 
agreeing core values and key messages; collaborating by exchanging 
information and pooling resources; and coordination by designated 
campaign leaders. By identifying factors contributing to success-
ful public health advocacy, the article provides valuable lessons for 
those with an interest in effective public health policy and has poten-
tial to inform the development of effective public health advocacy 
at European and national levels. The analysis of advocacy on EU 
smoke-free policy might help advocates engaged in on-going debates 
on tobacco control and other policy areas, including alcohol and 
food policy, to build successful alliances for public health.
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